Cohort study with Marino et al. (2015) No III-2 USA n: 455 TRUSGB Major infection concurrent controls Tertiary Age: median 65 Cores: NR UTI Non-consecutive hospital PSA: NR Enema: NR Retrospective Prior biopsy: NR Needle: NR Mohammed et al. No Comparative study III-3 Ireland n: 286 TRUSGB Bacteraemia (2016) with historical Hospitalisation Tertiary Age: Cores: 6/12 controls hospital Group A: 59.6 (6.6) Enema: 100 Consecutive Group B: 61 (6.2) Needle: NR Retrospective PSA: Group A: 9 (5.1) Group B: 8.5 (4.6) Prior biopsy: mix Petteffi et al. (2002) No RCT II Brazil n: 105 TRUSGB UTI Consecutive Multiple Age: Cores: NR Fever hospitals Hospitalisation Prospective Group A: 65 (7) Enema: 100 Group B: 64 (8) Needle: 18G PSA: NR Prior biopsy: NR Comparative study Turkey Tertiary Sahin et al. (2015) No III-2 n: 480 TRUSGB Minor infection with concurrent hospital Age: 65.9 (7.8) Cores: 12 Major infection controls PSA: 12.5 (18.8) Enema: 100 UTI Non-consecutive Prior biopsy: 28 Needle: 18G Prospective
Marino et al. (2015) No Cohort study with concurrent controls Non-consecutive Retrospective III-2 USA Tertiary hospital n: 455 Age: median 65 PSA: NR Prior biopsy: NR TRUSGB Cores: NR Enema: NR Needle: NR Major infection UTI Mohammed et al. (2016) No Comparative study with historical controls Consecutive Retrospective III-3 Ireland Tertiary hospital n: 286 Age: Group A: 59.6 (6.6) Group B: 61 (6.2) PSA: Group A: 9 (5.1) Group B: 8.5 (4.6) Prior biopsy: mix TRUSGB Cores: 6/12 Enema: 100 Needle: NR Bacteraemia Hospitalisation Petteffi et al. (2002) No RCT Consecutive Prospective II Brazil Multiple hospitals n: 105 Age: Group A: 65 (7) Group B: 64 (8) PSA: NR Prior biopsy: NR TRUSGB Cores: NR Enema: 100 Needle: 18G UTI Fever Hospitalisation Sahin et al. (2015) No Comparative study with concurrent controls Non-consecutive Prospective III-2 Turkey Tertiary hospital n: 480 Age: 65.9 (7.8) PSA: 12.5 (18.8) Prior biopsy: 28 TRUSGB Cores: 12 Enema: 100 Needle: 18G Minor infection Major infection UTI
1397_Final_MSAC_Assessment_Report.docx